These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3769874)

  • 21. Responses of the L5178Y tk+/tk- mouse lymphoma cell forward mutation assay. II: 18 coded chemicals.
    McGregor DB; Brown A; Cattanach P; Edwards I; McBride D; Caspary WJ
    Environ Mol Mutagen; 1988; 11(1):91-118. PubMed ID: 3338442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The utilization of trifluorothymidine (TFT) to select for thymidine kinase-deficient (TK-/-) mutants from L5178Y/TK+/- mouse lymphoma cells.
    Moore-Brown MM; Clive D; Howard BE; Batson AG; Johnson KO
    Mutat Res; 1981 Oct; 85(5):363-78. PubMed ID: 6795499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of mutations in mouse lymphoma L5178Y cells by ethylmethanesulphonate, benzidine and benzo[a]pyrene.
    Henderson L; Ransome S; Brabbs C; Tinner A; Davies S
    Mutagenesis; 1990; 5 Suppl():27-34. PubMed ID: 2184317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells. I. Application to genetic toxicological testing.
    Amacher DE; Paillet S; Ray VA
    Mutat Res; 1979 Dec; 64(6):391-406. PubMed ID: 392313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytogenetic characterization of the L5178Y TK+/-3.7.2C mouse lymphoma cell line.
    Sawyer J; Moore MM; Clive D; Hozier J
    Mutat Res; 1985 Oct; 147(5):243-53. PubMed ID: 4047079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ascorbate is detectably mutagenic in the L5178Y TK+/- cell mutation assay.
    Amacher DE; Paillet SC
    Cancer Lett; 1981 Nov; 14(2):151-8. PubMed ID: 7317878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular analysis of mutations at the tk locus of L5178Y mouse-lymphoma cells induced by ethyl methanesulphonate and mitomycin C.
    Davies MJ; Phillips BJ; Rumsby PC
    Mutat Res; 1993 Dec; 290(2):145-53. PubMed ID: 7694105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytogenetic analysis of the L5178Y/TK+/- leads to TK-/- mouse lymphoma mutagenesis assay system.
    Hozier J; Sawyer J; Moore M; Howard B; Clive D
    Mutat Res; 1981 Nov; 84(1):169-81. PubMed ID: 7329431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole genome sequencing analysis of small and large colony mutants from the mouse lymphoma assay.
    Guo X; Pan B; Seo JE; Chen Y; Yan J; Mei N; Chen T
    Arch Toxicol; 2018 Dec; 92(12):3585-3595. PubMed ID: 30328498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutant frequencies and loss of heterozygosity induced by N-ethyl-N-nitrosourea in the thymidine kinase gene of L5178Y/TK(+/-)-3.7.2C mouse lymphoma cells.
    Chen T; Harrington-Brock K; Moore MM
    Mutagenesis; 2002 Mar; 17(2):105-9. PubMed ID: 11880538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mutagenicity of 2-amino-N6-hydroxyadenine to L5178Y tk +/- 3.7.2C mouse lymphoma cells: measurement of mutations to ouabain, 6-thioguanine and trifluorothymidine resistance, and the induction of micronuclei.
    Cole J; Richmond FN; Bridges BA
    Mutat Res; 1991 Aug; 253(1):55-62. PubMed ID: 1908053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Procarbazine is a potent mutagen at the heterozygous thymidine kinase (tk +/-) locus of mouse lymphoma assay.
    Clive D; Turner N; Krehl R
    Mutagenesis; 1988 Mar; 3(2):83-7. PubMed ID: 3288842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The evaluation of the use of 10% rather than 20% horse serum in the cloning and selection of TK-/- mutants of L5178Y/TK+/- mouse lymphoma cells.
    Moore MM; Loud K; Templeton RK
    Mutat Res; 1984 Aug; 140(4):215-8. PubMed ID: 6472332
    [No Abstract]   [Full Text] [Related]  

  • 34. In situ and suspension protocols for chemically-induced mutation at the tk locus in L5178Y MOLY cells: dose response and colony size distribution.
    Spencer DL; Caspary WJ
    Mutat Res; 1994 Oct; 322(4):291-300. PubMed ID: 7523923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stability of tk-/- mutants of L5178Y mouse lymphoma cells in Fischer's medium.
    Clive D; Krehl R
    Mutat Res; 1991 Aug; 260(4):409-13. PubMed ID: 1908056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromosome painting analysis of spontaneous and methyl methanesulfonate-induced trifluorothymidine-resistant L5178Y cell colonies.
    Zhang LS; Honma M; Matsuoka A; Suzuki T; Sofuni T; Hayashi M
    Mutat Res; 1996 Oct; 370(3-4):181-90. PubMed ID: 8917664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mutagenic potency of 4 agents at the thymidine kinase locus in mouse lymphoma L5178Y cells in vitro: effects of exposure time.
    Edgar DH
    Mutat Res; 1985; 157(2-3):199-204. PubMed ID: 4022042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multi-endpoint genotoxic assay using L5178Y (Tk(+/-) -3.7.2c) cells.
    Ogawa I; Furukawa S; Abe M; Tanaka Y; Hayashi S; Usuda K
    J Toxicol Sci; 2009 Oct; 34(5):547-53. PubMed ID: 19797863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutagenicity of 2-amino-N6-hydroxyadenine (AHA) at three loci in L5178Y/tk+/- mouse lymphoma cells: molecular and preliminary cytogenetic characterizations of AHA-induced tk-/- mutants.
    Clive D; Glover P; Krehl R; Poorman-Allen P
    Mutat Res; 1991 Aug; 253(1):73-82. PubMed ID: 1651447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutagenicity and clastogenicity of proflavin in L5178Y/TK +/- -3.7.2.C cells.
    DeMarini DM; Brock KH; Doerr CL; Moore MM
    Mutat Res; 1988 Feb; 204(2):323-8. PubMed ID: 3343981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.